Mr. Chirfi Guindo - 02 Dec 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BEAM	Stock Option (Right to Buy)	Award	$0	+39,086		$0.000000	39,086	02 Dec 2024	Common Stock	39,086	$28.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter, subject to the Reporting Person's continued service with the Company through each vesting date.